Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases
- PMID: 6490
- PMCID: PMC333168
- DOI: 10.1172/JCI108447
Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases
Abstract
Antibody-dependent cell-mediated cytotoxicity mediated by peripheral blood lymphocytes was studied in patients with systemic lupus erythematosus, polyarteritis nodosa. Sjogren's syndrome, and rheumatoid arthritis. The target cells were chicken erythrocytes coated with rabbit anti-chicken erythrocyte antibody. Antibody-dependent cell-mediated cytotoxic activity was normal in Sjogren's syndrome and rheumatoid arthritis but significantly decreased (P is less than 0.001) in active systemic lupus erythematosus and in two patients with polyarteritis nodosa. A partial regeneration of antibody-dependent cell-mediated cytotoxic activity was obtained by treatment with pronase and DNase followed by overnight incubation. Sera from patients with systemic lupus erythematosus inhibited antibody-dependent cell-mediated cytotoxic activity of normal lymphocytes. The inhibitory activity was studied by specific immunoadsorption and sucrose density geadient ultracentrifugation. Removal of IgG but not IgM greatly reduced inhibition. Inhibitory factors were present in 7S and heavier fractions containing IgG. Five systemic lupus erythematosus patients were studied serially to determine if improvement in clinical status could be correlated with a decrease in serum inhibitory factors as studied by inhibition of normal antibody-dependent cell-mediated cytotoxicity. Indeed, a greater serum inhibitory capacity was found in each patient during periods of greater disease activity.
Similar articles
-
In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.Clin Exp Immunol. 1976 Dec;26(3):563-73. Clin Exp Immunol. 1976. PMID: 795579 Free PMC article.
-
Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.In Vivo. 1994 Jul-Aug;8(4):577-80. In Vivo. 1994. PMID: 7534494
-
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.J Immunol. 1985 Sep;135(3):2005-14. J Immunol. 1985. PMID: 4020137
-
The immunology of rheumatoid diseases.Clin Symp. 1979;31(4):1-36. Clin Symp. 1979. PMID: 45382 Review. No abstract available.
-
[Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].Ter Arkh. 1984;56(10):130-6. Ter Arkh. 1984. PMID: 6084315 Review. Russian. No abstract available.
Cited by
-
Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.J Clin Invest. 1980 Aug;66(2):353-60. doi: 10.1172/JCI109863. J Clin Invest. 1980. PMID: 6995484 Free PMC article.
-
Clinical characteristics and risk factors of cardiovascular disease in systemic lupus erythematosus patients.Heart Vessels. 2025 Jul;40(7):665-675. doi: 10.1007/s00380-024-02508-0. Epub 2024 Dec 24. Heart Vessels. 2025. PMID: 39719523
-
Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.Clin Exp Immunol. 1983 Aug;53(2):363-70. Clin Exp Immunol. 1983. PMID: 6883808 Free PMC article.
-
Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.Clin Exp Immunol. 1981 Jun;44(3):603-10. Clin Exp Immunol. 1981. PMID: 7326870 Free PMC article.
-
T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.J Clin Invest. 1982 Apr;69(4):1026-38. doi: 10.1172/jci110506. J Clin Invest. 1982. PMID: 6978891 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources